Paper 18 - PRE-TREATMENT CTDNA BURDEN IS PROGNOSTIC AMONG PATIENTS WITH LOCALIZED EWING SARCOMA: A REPORT FROM THE LEOPARD STUDY

Author(s)

• 

  David Shulman, MD

  Assistant Professor
  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States

  Slides

Co-Author(s)

• KK

  Kelly Klega, MS

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• NC

  Nan Chen, MS

  Dana-Farber/Boston Children's Cancer and Blood Disorders Center
  Boston, Massachusetts, United States
• EG

  Elliot Gohn, BS

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• SS

  Sarah Sexton, BS

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• DH

  Donovan Henry, BS

  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• 

  Edwin Choy, MD PhD (he/him/his)

  Associate Professor
  Massachusetts General Hospital
  Boston, Massachusetts, United States
• WC

  William Cash, MD

  Children's Hospital of Atlanta
  Atlanta, Georgia, United States

Co-Author(s)

• 

  Christopher Kuo, M.D (he/him/his)

  Clinical Instructor of Pediatrics
  Children's Hospital Los Angeles
  Los Angeles, California, United States

Co-Author(s)

• KS

  Kris Ann Schultz, MD

  Children's Minnesota Hematology Oncology
  Minneapolis, Minnesota, United States
• LM

  Leo Mascarenhas, MD, MS

  Cedars-Sinai Medical Center, California, CA, USA
  California, California, United States
• RB

  Rochelle Bagatell, MD

  Children's Hospital of Philadelphia
  Philadelphia, Pennsylvania, United States
• BT

  Brian Turpin, DO

  Cincinnati Children's
  Cincinnati, Ohio, United States
• BS

  Bhuvana Setty, MD

  Nationwide Children's Hospital
  Columbus, Ohio, United States
• BD

  Bradley Denardo, MD

  Hasbro Children's Hospital
  Providence, Rhode Island, United States
• DH

  Douglas S. Hawkins, MD

  Seattle Children’s Hospital, University of Washington
  Seattle, Washington, United States
• MB

  Michael Bishop, MD

  St. Jude Children's Research Hospital
  Memphis, Tennessee, United States
• AS

  Avanthi Shah, MD

  UT Southwestern Medical Center
  Dallas, Texas, United States
• LM

  Luke Maese, DO

  University of Utah
  Salt Lake City, Utah, United States
• WL

  Wendy London, PhD

  Dana-Farber/Boston Children's Cancer and Blood Disorders Center
  Boston, Massachusetts, United States
• SD

  Steven G. DuBois, MD, MS

  Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA
  Boston, Massachusetts, United States
• BC

  Brian Crompton, MD

  Department of Pediatrics, Dana-Farber / Boston Children’s Cancer and Blood Disorders Center Harvard Medical School
  Boston, Massachusetts, United States